Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon A Jackson

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Nucleic Acids Research|December 18, 2024
Genome-wide identification of bacterial genes contributing to nucleus-forming jumbo phage infectionKate R Harding, Lucia M Malone, Natalie A P Kyte, et al.
Journal of Structural Biology|June 11, 2021
Crystal structure of the anti-CRISPR repressor Aca2Ben Usher, Nils Birkholz, Izaak N Beck, et al.
Nature Communications|October 4, 2016
Interference-driven spacer acquisition is dominant over naive and primed adaptation in a native CRISPR-Cas systemRaymond H J Staals, Simon A Jackson, Ambarish Biswas, et al.
RNA Biology|August 31, 2018
Bioinformatic evidence of widespread priming in type I and II CRISPR-Cas systemsThomas J Nicholson, Simon A Jackson, Bradley I Croft, et al.
Nature Microbiology|December 11, 2019
A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunityLucia M Malone, Suzanne L Warring, Simon A Jackson, et al.
Nucleic Acids Research|August 17, 2021
The Rsm (Csr) post-transcriptional regulatory pathway coordinately controls multiple CRISPR-Cas immune systemsAroa Rey Campa, Leah M Smith, Hannah G Hampton, et al.
Journal of Molecular Biology|March 9, 2018
AbiEi Binds Cooperatively to the Type IV abiE Toxin-Antitoxin Operator Via a Positively-Charged Surface and Causes DNA Bending and Negative AutoregulationHannah G Hampton, Simon A Jackson, Robert D Fagerlund, et al.
Elife|August 23, 2017
Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systemsSukrit Silas, Patricia Lucas-Elio, Simon A Jackson, et al.
Elife|April 5, 2018
Correction: Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systemsSukrit Silas, Patricia Lucas-Elio, Simon A Jackson, et al.
Nucleic Acids Research|October 4, 2021
Identification and classification of antiviral defence systems in bacteria and archaea with PADLOC reveals new system typesLeighton J Payne, Thomas C Todeschini, Yi Wu, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Nucleic Acids Research|December 18, 2024
Genome-wide identification of bacterial genes contributing to nucleus-forming jumbo phage infectionKate R Harding, Lucia M Malone, Natalie A P Kyte, et al.
Journal of Structural Biology|June 11, 2021
Crystal structure of the anti-CRISPR repressor Aca2Ben Usher, Nils Birkholz, Izaak N Beck, et al.
Nature Communications|October 4, 2016
Interference-driven spacer acquisition is dominant over naive and primed adaptation in a native CRISPR-Cas systemRaymond H J Staals, Simon A Jackson, Ambarish Biswas, et al.
RNA Biology|August 31, 2018
Bioinformatic evidence of widespread priming in type I and II CRISPR-Cas systemsThomas J Nicholson, Simon A Jackson, Bradley I Croft, et al.
Nature Microbiology|December 11, 2019
A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunityLucia M Malone, Suzanne L Warring, Simon A Jackson, et al.
Nucleic Acids Research|August 17, 2021
The Rsm (Csr) post-transcriptional regulatory pathway coordinately controls multiple CRISPR-Cas immune systemsAroa Rey Campa, Leah M Smith, Hannah G Hampton, et al.
Journal of Molecular Biology|March 9, 2018
AbiEi Binds Cooperatively to the Type IV abiE Toxin-Antitoxin Operator Via a Positively-Charged Surface and Causes DNA Bending and Negative AutoregulationHannah G Hampton, Simon A Jackson, Robert D Fagerlund, et al.
Elife|August 23, 2017
Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systemsSukrit Silas, Patricia Lucas-Elio, Simon A Jackson, et al.
Elife|April 5, 2018
Correction: Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systemsSukrit Silas, Patricia Lucas-Elio, Simon A Jackson, et al.
Nucleic Acids Research|October 4, 2021
Identification and classification of antiviral defence systems in bacteria and archaea with PADLOC reveals new system typesLeighton J Payne, Thomas C Todeschini, Yi Wu, et al.
Pageof 6